These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

257 related articles for article (PubMed ID: 25133559)

  • 1. [Alterations of intraocular pressure in comparison of self- and external-administered topical antiglaucomatosa during diurnal intraocular pressure measurements].
    Böhm MR; Lill TM; Eter N; Prokosch-Willing V
    Klin Monbl Augenheilkd; 2014 Aug; 231(8):810-7. PubMed ID: 25133559
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intraocular pressure control over 24 hours using travoprost and timolol fixed combination administered in the morning or evening in primary open-angle and exfoliative glaucoma.
    Konstas AG; Tsironi S; Vakalis AN; Nasr MB; Stewart JA; Nelson LA; Stewart WC
    Acta Ophthalmol; 2009 Feb; 87(1):71-6. PubMed ID: 19178390
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluating eye drop instillation technique in glaucoma patients.
    Gupta R; Patil B; Shah BM; Bali SJ; Mishra SK; Dada T
    J Glaucoma; 2012 Mar; 21(3):189-92. PubMed ID: 21336146
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Relation between office intraocular pressure and 24-hour intraocular pressure in patients with primary open-angle glaucoma treated with a combination of topical antiglaucoma eye drops.
    Nakakura S; Nomura Y; Ataka S; Shiraki K
    J Glaucoma; 2007 Mar; 16(2):201-4. PubMed ID: 17473730
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intraocular pressure elevation within the first 24 hours after cataract surgery in patients with glaucoma or exfoliation syndrome.
    Levkovitch-Verbin H; Habot-Wilner Z; Burla N; Melamed S; Goldenfeld M; Bar-Sela SM; Sachs D
    Ophthalmology; 2008 Jan; 115(1):104-8. PubMed ID: 17561259
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Monocular trial of intraocular pressure-lowering medication: a prospective study.
    King AJ; Uppal S; Rotchford AP; Lakshumanan A; Abedin A; Henry E
    Ophthalmology; 2011 Nov; 118(11):2190-5. PubMed ID: 21724262
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dorzolamide/timolol combination versus concomitant administration of brimonidine and timolol: six-month comparison of efficacy and tolerability.
    Sall KN; Greff LJ; Johnson-Pratt LR; DeLucca PT; Polis AB; Kolodny AH; Fletcher CA; Cassel DA; Boyle DR; Skobieranda F
    Ophthalmology; 2003 Mar; 110(3):615-24. PubMed ID: 12623832
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intraocular pressure-lowering efficacy of brinzolamide when added to travoprost/timolol fixed combination as adjunctive therapy.
    Goldberg I; Crowston JG; Jasek MC; Stewart JA; Stewart WC;
    J Glaucoma; 2012 Jan; 21(1):55-9. PubMed ID: 21048504
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of the nocturnal effects of once-daily timolol and latanoprost on intraocular pressure.
    Liu JH; Kripke DF; Weinreb RN
    Am J Ophthalmol; 2004 Sep; 138(3):389-95. PubMed ID: 15364220
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Daily and nightly fluctuation of intraocular pressure and blood pressure in glaucoma and non-glaucoma patients].
    Chiseliţă D; Moţoc I; Danielescu C
    Oftalmologia; 2008; 52(1):119-25. PubMed ID: 18714502
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A phase 2, randomized, dose-response trial of taprenepag isopropyl (PF-04217329) versus latanoprost 0.005% in open-angle glaucoma and ocular hypertension.
    Schachar RA; Raber S; Courtney R; Zhang M
    Curr Eye Res; 2011 Sep; 36(9):809-17. PubMed ID: 21851167
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Topical and oral ketorolac administration increases the intraocular pressure-lowering effect of latanoprost.
    Costagliola C; Campa C; Perri P; Parmeggiani F; Romano MR; Incorvaia C
    Curr Eye Res; 2008 May; 33(5):477-82. PubMed ID: 18568885
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of latanoprost on the diurnal variations in the intraocular and ocular perfusion pressure in normal tension glaucoma.
    Ishibashi S; Hirose N; Tawara A; Kubota T
    J Glaucoma; 2006 Oct; 15(5):354-7. PubMed ID: 16988595
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Circadian intraocular pressure control with dorzolamide versus timolol maleate add-on treatments in primary open-angle glaucoma patients using latanoprost.
    Tamer C; Oksüz H
    Ophthalmic Res; 2007; 39(1):24-31. PubMed ID: 17164574
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of dorzolamide 2% added to timolol maleate 0.5% on intraocular pressure, retrobulbar blood flow, and the progression of visual field damage in patients with primary open-angle glaucoma: a single-center, 4-year, open-label study.
    Martínez A; Sánchez M
    Clin Ther; 2008 Jun; 30(6):1120-34. PubMed ID: 18640468
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Asymmetry of 24-hour intraocular pressure reduction by topical ocular hypotensive medications in fellow eyes.
    Liu JH; Realini T; Weinreb RN
    Ophthalmology; 2011 Oct; 118(10):1995-2000. PubMed ID: 21676464
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intraocular pressure-lowering effects of latanoprost monotherapy versus latanoprost or pilocarpine in combination with timolol: a randomized, observer-masked multicenter study in patients with open-angle glaucoma. Italian Latanoprost Study Group.
    Bucci MG
    J Glaucoma; 1999 Feb; 8(1):24-30. PubMed ID: 10084271
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Meta-analysis of 24-hour intraocular pressure studies evaluating the efficacy of glaucoma medicines.
    Stewart WC; Konstas AG; Nelson LA; Kruft B
    Ophthalmology; 2008 Jul; 115(7):1117-1122.e1. PubMed ID: 18082886
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy and safety of the fixed combinations latanoprost/timolol versus dorzolamide/timolol in patients with elevated intraocular pressure.
    Shin DH; Feldman RM; Sheu WP;
    Ophthalmology; 2004 Feb; 111(2):276-82. PubMed ID: 15019375
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sustained effect of travoprost on diurnal and nocturnal intraocular pressure.
    Sit AJ; Weinreb RN; Crowston JG; Kripke DF; Liu JH
    Am J Ophthalmol; 2006 Jun; 141(6):1131-3. PubMed ID: 16765686
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.